Congenital sensory neuropathy with anhidrosis.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMC 2019926)

Published in Arch Dis Child on February 01, 1968

Authors

F Vassella, H M Emrich, R Kraus-Ruppert, F Aufdermaur, O Tönz

Articles cited by this

The chemical transmission of secretory impulses to the sweat glands of the cat. J Physiol (1934) 9.20

Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease. Pediatrics (1953) 5.71

The human cardiovascular response to fluothane anaesthesia. Br J Anaesth (1956) 4.37

Hereditary sensory radicular neuropathy. J Neurol Neurosurg Psychiatry (1951) 3.03

Physiological significance of the sweat response to adrenaline in man. J Physiol (1951) 1.89

Some sensory syndromes in children: indifference to pain and sensory neuropathy. J Neurol Neurosurg Psychiatry (1959) 1.73

Congenital insensitivity to pain with anhydrosis. A unique syndrome in two male siblings. Arch Neurol (1963) 1.64

Abnormal catechol amine metabolism in familial dysautonomia. N Engl J Med (1963) 1.44

The sweat test in cystic fibrosis. A comparison of overnight sweat collection versus the pilocarpine iontophoresis method. J Pediatr (1966) 1.22

Congenital familial sensory neuropathy with anhidrosis. J Pediatr (1966) 1.18

Congenital absence of pain. Report of a case and experimental studies. Arch Dermatol (1962) 1.10

Chromosome trisomy of group 13-15 in two cases of generalised congenital analgesia. Lancet (1963) 1.07

Familial dysautonomia. Adv Pediatr (1957) 1.07

Congenital generalized indifference to pain (congenital analgia). Am J Dis Child (1960) 1.03

[Congenital analgia (congenital generalized pain indifference)]. Helv Paediatr Acta (1957) 1.03

Congenital universal insensitivity to pain. Brain (1960) 0.97

Indifference to pain in low-grade mental defectives. Br Med J (1954) 0.87

Hereditary insensitivity to pain. Trans Am Neurol Assoc (1960) 0.85

[Separation of different compounds in sweat, depending upon sweat flow rate]. Pflugers Arch Gesamte Physiol Menschen Tiere (1966) 0.83

Articles by these authors

Psychotomimesis mediated by kappa opiate receptors. Science (1986) 3.60

A viro-psycho-immunological disease-model of a subtype affective disorder. Pharmacopsychiatry (1998) 2.08

Proliferation and turnover of glial cells in the forebrain of young adult mice as studied by repeated injections of 3 H-thymidine over a prolonged period of time. J Comp Neurol (1973) 2.03

Dopamine transporter binding in Gilles de la Tourette syndrome. J Neurol (2000) 1.79

Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet (1997) 1.62

Multiple lysosomal deficiency due to enzyme leakage? N Engl J Med (1971) 1.55

Hepatic capillariasis in a 1-year-old child. Eur J Pediatr (1990) 1.54

Epidermolysis bullosa simplex with mottled pigmentation. J Am Acad Dermatol (1989) 1.44

Elevated endogenous cannabinoids in schizophrenia. Neuroreport (1999) 1.38

Rotatory seizures in a patient with tuberous sclerosis. Epileptic Disord (1999) 1.35

N-acetylglutamate synthetase deficiency: a disorder of ammonia detoxication. N Engl J Med (1981) 1.31

"I-cell" disease: leakage of lysosomal enzymes into extracellular fluids. N Engl J Med (1971) 1.27

Familial epilepsy and yellow teeth--a disease of the CNS associated with enamel hypoplasia. Helv Paediatr Acta (1974) 1.26

Discrepant target detection and action monitoring in obsessive-compulsive disorder. Psychiatry Res (2001) 1.19

UNICEF/WHO baby-friendly hospital initiative: does the use of bottles and pacifiers in the neonatal nursery prevent successful breastfeeding? Neonatal Study Group. Eur J Pediatr (1997) 1.17

The myelin-pathogenesis puzzle in schizophrenia: a literature review. Mol Psychiatry (2007) 1.16

Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report. Pharmacol Biochem Behav (1983) 1.15

Brain-stem auditory evoked potentials and early somatosensory evoked potentials in neurointensively treated comatose children. Am J Dis Child (1983) 1.15

Different effects of nabilone and cannabidiol on binocular depth inversion in Man. Pharmacol Biochem Behav (2000) 1.13

[The importance of the endogenous cannabinoid system in various neuropsychiatric disorders]. Fortschr Neurol Psychiatr (2000) 1.09

Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand (2004) 1.08

N-acetylglutamate synthetase deficiency: diagnosis, management and follow-up of a rare disorder of ammonia detoxication. Eur J Pediatr (1991) 1.06

Intracranial lipomas. Neuropediatrics (1992) 1.04

Possible antidepressive effects of opioids: action of buprenorphine. Ann N Y Acad Sci (1982) 1.04

Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Pharmacopsychiatry (2002) 1.03

Audiovisual integration of speech is disturbed in schizophrenia: an fMRI study. Schizophr Res (2009) 1.03

Cogan's congenital ocular motor apraxia in two successive generations. Dev Med Child Neurol (1972) 1.00

Estradiol levels in psychotic disorders. Psychoneuroendocrinology (2001) 1.00

High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport (2000) 0.99

Morphological studies on neuroglial cells in the corpus callosum of the Jimpy mutant mouse. J Neuropathol Exp Neurol (1973) 0.97

Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology (Berl) (1999) 0.97

Conventional and spectral EEG analysis in children treated with cytotoxic agents. Eur J Cancer Clin Oncol (1982) 0.97

The syndrome of 'continuous muscle fiber activity.'. Arch Neurol (1978) 0.96

Altered inhibition of motor responses in Tourette Syndrome and Obsessive-Compulsive Disorder. Acta Neurol Scand (2001) 0.96

Reduced binocular depth inversion in schizophrenic patients. Schizophr Res (2002) 0.96

[Primary reactions in the visual process. Thermodynamic and kinetic influence of pH on the metarhodopsin I-II transition. Proton consumption as an effect of a conformation change (author's transl)]. Z Naturforsch C (1974) 0.95

Vitamin K1 concentration in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed-micellar preparation of phylloquinone. J Pediatr Gastroenterol Nutr (1993) 0.95

Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiatr Nervenkr (1970) (1980) 0.95

An artificial indicator for electric phenomena in biological membranes and interfaces. Naturwissenschaften (1969) 0.94

High-flux hemodialysis--an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol (2002) 0.93

Myelin differences in the central and peripheral nervous system in the 'Jimpy' mouse. J Neurochem (1971) 0.93

[Neonatal thrombocyte values in children with Down's syndrome and other autosome trisomies]. Helv Paediatr Acta (1979) 0.93

Phenylketonuria, a family study. Borderline intelligence in two siblings with mentally retarded children. Helv Paediatr Acta (1967) 0.92

Differential effects of emotional content on event-related potentials in word recognition memory. Neuropsychobiology (2001) 0.92

Iron absorption in cystic fibrosis. Lancet (1965) 0.92

Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload. Helv Paediatr Acta (1979) 0.91

Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry (2002) 0.91

Swelling of the third nerve in a child with transient oculomotor paresis: a possible cause of ophthalmoplegic migraine. Neuropediatrics (2000) 0.90

Mucolipidosis II (I-cell disease). A clinical and biochemical study. Acta Paediatr Scand (1974) 0.90

Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study. Addict Biol (2000) 0.89

Cannabinoid/anandamide system and schizophrenia: is there evidence for association? Pharmacopsychiatry (1998) 0.89

Benign migraine-like syndrome with CSF pleocytosis in children. Dev Med Child Neurol (1985) 0.89

Visual 3D illusion: a systems-theoretical approach to psychosis. Eur Arch Psychiatry Clin Neurosci (1996) 0.89

Further evidcence for an optical response of chloroplast bulk pigments to a light induced electrical field in photosynthesis. Z Naturforsch B (1969) 0.89

Mood cycles associated with normal pressure hydrocephalus. Am J Psychiatry (1996) 0.89

Possible use of amantadine in depression. Pharmacopsychiatry (1999) 0.88

[Liquid-manure gas intoxication in children using rural latrines]. Schweiz Med Wochenschr (1970) 0.88

Fewer beta-endorphin expressing arcuate nucleus neurons and reduced beta-endorphinergic innervation of paraventricular neurons in schizophrenics and patients with depression. Cell Mol Biol (Noisy-le-grand) (2002) 0.88

The late form of metachromatic leukodystrophy. II. Ultrastructural correlations with morphological and neurochemical findings. J Neurol Sci (1972) 0.88

The seeking and liking potentials of alprazolam. Am J Psychiatry (1988) 0.88

Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. Bipolar Disord (2000) 0.87

Congenital lymphoid leukaemia. Case report with chromosomal studies. Helv Paediatr Acta (1968) 0.87

Progressive neural muscular atrophy in a case of phenylketonuria. Dev Med Child Neurol (1975) 0.86

Nabilone increases choreatic movements in Huntington's disease. Mov Disord (1999) 0.86

A study of the late form (type Lundborg) of progressive myoclonic epilepsy. J Neurol Sci (1970) 0.86

Current and historical concepts of opiate treatment in psychiatric disorders. Int Clin Psychopharmacol (1988) 0.86

Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia. Biol Psychiatry (1985) 0.85

Antipsychotic effect of buprenorphine in schizophrenia. Am J Psychiatry (1987) 0.85

The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord (1985) 0.85

Emotion/cognition-coupling in word recognition memory of depressive patients: an event-related potential study. Psychiatry Res (2000) 0.84

Fundus photography in neonates, an approach to obtain indirect information on cerebral blood flow. Helv Paediatr Acta (1976) 0.84

Obstetrical lesions of the brachial plexus. Natural history in 34 personal cases. Eur Neurol (1982) 0.83

Is there some indication from behavioral effects of endorphins for their involvement in psychiatric disorders? Adv Biochem Psychopharmacol (1978) 0.83

[Separation of different compounds in sweat, depending upon sweat flow rate]. Pflugers Arch Gesamte Physiol Menschen Tiere (1966) 0.83

Inside a synesthete's head: a functional connectivity analysis with grapheme-color synesthetes. Neuropsychologia (2012) 0.83

The neural correlates of coloured music: a functional MRI investigation of auditory-visual synaesthesia. Neuropsychologia (2011) 0.82

Antidepressant effects of buprenorphine. Lancet (1982) 0.82

Disinhibited feedback as a cause of synesthesia: evidence from a functional connectivity study on auditory-visual synesthetes. Neuropsychologia (2012) 0.82

The effects of tetrahydrocannabinol on the recognition of emotionally charged words: an analysis using event-related brain potentials. Neuropsychobiology (1998) 0.82

[Neurological complications following tonsillectomy]. Schweiz Med Wochenschr (1991) 0.82

[Congenital muscular dystrophy]. Dtsch Z Nervenheilkd (1967) 0.82

Therapeutic effect of valproate in mania. Am J Psychiatry (1981) 0.81

Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol. Am J Psychiatry (1999) 0.81

Investigations of the kinetics of red cell pyruvate kinase in normal individuals and in a patient with pyruvate kinase deficiency. Nature (1966) 0.81

Niemann-Pick's disease. Clinical, biochemical and ultrastructural findings in a case of the infantile form. J Neurol (1975) 0.81

Diurnal variation of mood and the cortisol rhythm in depression and normal states of mind. Eur Arch Psychiatry Neurol Sci (1987) 0.81

[48,XXYY syndrome in a boy with essential tremor. Comparison with 120 cases from the literature]. Monatsschr Kinderheilkd (1992) 0.81

Cannabis in movement disorders. Forsch Komplementarmed (1999) 0.81

Hypodipsia-hypernatremia syndrome. Helv Paediatr Acta (1979) 0.80

[Therapy of diabetes insipidus centralis with chlorpropamid (diabinese) and carbamazepin (tegretol) in a child]. Schweiz Med Wochenschr (1972) 0.80

Apnoeic attacks as an isolated manifestation of epileptic seizures in infants. Eur J Paediatr Neurol (1998) 0.80

Renin-like (angiotensinogenase) activity in sweat of patients with cystic fibrosis and controls. Klin Wochenschr (1977) 0.80

Neurophysiological aspects of synesthetic experience. J Neuropsychiatry Clin Neurosci (1999) 0.80

Circadian rhythms in endogenous depression. Psychiatry Res (1985) 0.80

Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects. Neuropsychobiology (1999) 0.80

[Prognostic value of the EEG prior to the start and the discontinuation of anticonvulsive therapy]. Schweiz Rundsch Med Prax (1991) 0.79

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome. Acta Psychiatr Scand (1998) 0.79